Management of Neovascular Age-Related Macular Degeneration Treatment in France from 2008–2018: The Nationwide LANDSCAPE Study

Management of Neovascular Age-Related Macular Degeneration Treatment in France from 2008–2018: The Nationwide LANDSCAPE Study

Abstract Introduction The aim of this study was to describe the management of neovascular age-related macular degeneration (nAMD) in French patients between 2008 and 2018. Methods This was a retrospective longitudinal cohort study using exhaustive nationwide health records from the French National H...

Full description

Bibliographic Details
Main Authors:	Catherine P. Creuzot Garcher, Mayer Srour, Florian Baudin, Corinne Dot, Sylvia Nghiem-Buffet, Jean-Francois Girmens, Cedric Collin, Anne Ponthieux, Cécile Delcourt
Format:	Article
Language:	English
Published:	Adis, Springer Healthcare 2023-08-01
Series:	Ophthalmology and Therapy
Subjects:	Neovascular age-related macular degeneration Système National des Données de Santé Anti-VEGF Real-world management
Online Access:	https://doi.org/10.1007/s40123-023-00772-3

Similar Items

Incidence and Prevalence of Neovascular Age-Related Macular Degeneration in France between 2008 and 2018
by: Catherine P. Creuzot-Garcher, MD, PhD, et al.
Published: (2022-03-01)

Epidemiology of Treated Diabetes Ocular Complications in France 2008–2018—The LANDSCAPE French Nationwide Study
by: Catherine Creuzot-Garcher, et al.
Published: (2022-10-01)

Les Centres de collaboration nationale du Canada : Faciliter la prise de décisions informées par des données probantes en santé publique
by: Alejandra Dubois, et al.
Published: (2020-02-01)

Neovascular Remodeling and Subretinal Fibrosis as Biomarkers for Predicting Incomplete Response to Anti-VEGF Therapy in Neovascular Age-Related Macular Degeneration
by: Jing Wu, et al.
Published: (2022-04-01)

The Architecture of Macular Neovascularizations Predicts Treatment Responses to Anti-VEGF Therapy in Neovascular AMD
by: Henrik Faatz, et al.
Published: (2022-11-01)

L'utilisation de données de recherche sans votre accord lors d'un partenariat de santé mondiale
by: Valéry Ridde
Published: (2018-02-01)

Comparison of ranibizumab and bevacizumab in neovascular age-related macular degeneration
by: Huseyin Serdarogullari, et al.
Published: (2014-05-01)

Clinical Features of Untreated Type 2 Macular Telangiectasia and Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Macular Neovascularization
by: Müge Çoban Karataş, et al.
Published: (2022-02-01)

Current and Novel Therapeutic Approaches for Treatment of Neovascular Age-Related Macular Degeneration
by: Reem H. ElSheikh, et al.
Published: (2022-11-01)

Le Centre de collaboration nationale des méthodes et outils (CCNMO) : soutenir la prise de décisions fondée sur des données probantes en santé publique au Canada
by: Heather Husson, et al.
Published: (2021-05-01)

Neovascular Age-Related Macular Degeneration (nAMD): A Review of Emerging Treatment Options
by: Tan CS, et al.
Published: (2022-03-01)

Temporary Vitelliform Regression After Intravitreal Ranibizumab Injection for Macular Neovascularization Complicating Best Disease
by: Fayed A
Published: (2022-10-01)

Treatment Strategies for Anti-VEGF Resistance in Neovascular Age-Related Macular Degeneration by Targeting Arteriolar Choroidal Neovascularization
by: Yingbin Fu, et al.
Published: (2024-02-01)

Personalized Approach in Treatment of Neovascular Age-Related Macular Degeneration
by: Radina Kirkova, et al.
Published: (2022-09-01)

Efficacy of anti-VEGF combined with compound trabeculectomy in the treatment of neovascular glaucoma
by: Cao-Yu Sun, et al.
Published: (2020-09-01)

Use of Bevacizumab in the Treatment of Corneal Neovascularization
by: Tuba Çelik, et al.
Published: (2015-01-01)

Results of Intravitreal Anti-VEGF Injection in Choroidal Neovascularization Caused by Pathologies Other Than Age-Related Macular Degeneration
by: Mehmet Ozveren
Published: (2020-08-01)

Conbercept for Treatment of Neovascular Age-Related Macular Degeneration and Visual Impairment due to Diabetic Macular Edema or Pathologic Myopia Choroidal Neovascularization: A Systematic Review and Meta-Analysis
by: Pengxiang Zhou, et al.
Published: (2021-10-01)

VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy
by: Alessandro Arrigo, et al.
Published: (2022-12-01)

La règlementation du traitement des données de santé au Mali à l’ère du numérique : entre interdiction et inadaptation
by: Mahamadou Aly HAIDARA
Published: (2022-11-01)

Pharmacogenomic study on anti-VEGF medicine in treatment of macular Neovascular diseases: a study protocol for a prospective observational study
by: Jin Jing, et al.
Published: (2018-07-01)

Neovascular Age-Related Macular Degeneration: Therapeutic Management and New-Upcoming Approaches
by: Federico Ricci, et al.
Published: (2020-11-01)

Aflibercept Treatment Results and Association with Baseline Characteristics in Cases of Newly Diagnosed Neovascular Age-Related Macular Degeneration
by: Pelin Kıyat, et al.
Published: (2021-06-01)

Myopic choroidal neovascular membrane: A retrospective study
by: S Sindhu, et al.
Published: (2016-01-01)

Neovascular age-related macular degeneration: intraocular inflammatory cytokines in the poor responder to ranibizumab treatment
by: Pongsachareonnont P, et al.
Published: (2018-09-01)

Emerging therapeutic strategies for unmet need in neovascular age-related macular degeneration
by: Levon M. Khachigian, et al.
Published: (2023-02-01)

Real-World Data on Faricimab Switching in Treatment-Refractory Neovascular Age-Related Macular Degeneration
by: Benjamin Ng, et al.
Published: (2024-01-01)

Manipulation of autophagy: a novelly potential therapeutic strategy for retinal neovascularization
by: Rong Li, et al.
Published: (2018-04-01)

Type 3 macular neovascularization in a patient with pentosan polysulfate maculopathy
by: Elodie Bousquet, et al.
Published: (2023-03-01)

LRG1 Expression Is Elevated in the Eyes of Patients with Neovascular Age-Related Macular Degeneration
by: Lucia Mundo, et al.
Published: (2021-08-01)

A Review of Neovascular Glaucoma: Etiology, Pathogenesis, Diagnosis, and Treatment
by: Danielė Urbonavičiūtė, et al.
Published: (2022-12-01)

Impact of Delayed Intravitreal Anti-Vascular Endothelial Growth Factor (VEGF) Therapy Due to the Coronavirus Disease Pandemic on the Prognosis of Patients with Neovascular Age-Related Macular Degeneration
by: Jae-Gon Kim, et al.
Published: (2022-04-01)

Recurrence of Macular Hole Retinal Detachment after Intravitreal Ranibizumab Injection for the Treatment of Choroidal Neovascularization from the Remaining Macular Hole Edge
by: Keiko Otsuka, et al.
Published: (2012-12-01)

Aperçu - Tendances en matière de cancer au Canada, 1984-2015
by: Alain A. Demers, et al.
Published: (2019-01-01)

Delivery of nVEGFi using AAV8 for the treatment of neovascular age-related macular degeneration
by: Kaiqin She, et al.
Published: (2022-03-01)

New Therapies of Neovascular AMD—Beyond Anti-VEGFs
by: Praveen Yerramothu
Published: (2018-07-01)

Biosimilar versus InnovAtor MoLecule of RAnibizumab in Neovascular Age-Related MaCular DEgeneration (The BALANCE Trial): Real-World Evidence
by: Chakraborty D, et al.
Published: (2023-04-01)

New and Innovative Treatments for Neovascular Age-Related Macular Degeneration (nAMD)
by: Prem Patel, et al.
Published: (2021-05-01)

Bacillary Layer Detachment in Neovascular Age-Related Macular Degeneration: Case Series
by: Filomena Palmieri, et al.
Published: (2023-03-01)

Efficacy of Intravitreal injection of 2-Methoxyestradiol in regression of neovascularization of a retinopathy of prematurity rat model
by: Azza Mohamed Ahmed Said, et al.
Published: (2017-04-01)